Skip to main content

Advertisement

SpringerLink
Log in

Changes in bone resorption markers among Japanese patients with postmenopausal osteoporosis treated with alendronate and risedronate

  • SHORT COMMUNICATION
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

We compared the abilities of alendronate and risedronate to reduce levels of urinary cross-1inked N-telopeptides of type I collagen (NTX) in Japanese postmenopausal women. The patients were randomly divided into two groups (alendronate, 5 mg/day, n = 61; risedronate, 2.5 mg/day, n = 60). All patients had taken all medication prescribed for the first month and at least 90% of that prescribed for each of the following 6 months. Urinary NTX was measured at baseline, as well as at 1 and 6 months after starting treatment. According to the guidelines of the Japan Osteoporosis Society, the minimum significant change (MSC) for urinary NTX is defined as a 35% decrease from baseline and the cutoff level for a high risk of future fracture is 54.3 nmol bone collagen equivalent (BCE)/mmol·Cr. The NTX reduction rates at 1 and 6 months were greater with alendronate than with risedronate, but the difference was not significant. The rate of patients with a reduction in the MSC at 1 month was greater with alendronate than with risedronate, but the difference did not reach significance. Alendronate reduced NTX at 1 month significantly more in patients with a high risk of fracture than risedronate, but the difference was no longer significant at 6 months. The rate of MSC did not significantly differ between the two groups. In conclusion, alendronate decreases bone resorption markers more obviously and rapidly than risedronate, especially in high risk for fracture, but not significantly according to the guidelines of the Japan Osteoporosis Society.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. InstitutionalAuthorNameNIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) ArticleTitleThiazide use and reduced sodium intake for prevention of osteoporosis JAMA 285 785–795 Occurrence Handle10.1001/jama.285.6.785

    Article  Google Scholar 

  2. PD Delmas E Seeman (2004) ArticleTitleChanges in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy Bone (NY) 34 599–604 Occurrence Handle1:CAS:528:DC%2BD2cXisF2ntL4%3D

    CAS  Google Scholar 

  3. P Garnero P Dargent-Molina D Hans AM Schott G Breart et al. (1998) ArticleTitleDo markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study Osteoporos Int 8 563–569 Occurrence Handle10326062 Occurrence Handle10.1007/s001980050100 Occurrence Handle1:STN:280:DyaK1M3lsl2isA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  4. RA Hannon R Eastell (2003) ArticleTitleBiochemical markers of bone turnover and fracture prediction J Br Menopause Soc 9 10–15 Occurrence Handle12804307 Occurrence Handle10.1258/136218003100322080

    Article  PubMed  Google Scholar 

  5. O Bruyere J Collette P Delmas A Rouillon C Roux et al. (2003) ArticleTitleInterest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women Maturities 44 259–265 Occurrence Handle10.1016/S0378-5122(03)00042-2 Occurrence Handle1:CAS:528:DC%2BD3sXivFertLY%3D

    Article  CAS  Google Scholar 

  6. R Eastell I Barton RA Hannon A Chines P Garnero et al. (2003) ArticleTitleRelationship of early changes in bone resorption to the reduction in fracture risk with risedronate J Bone Miner Res 18 1051–1056 Occurrence Handle12817758 Occurrence Handle10.1359/jbmr.2003.18.6.1051 Occurrence Handle1:CAS:528:DC%2BD3sXkslOhsb0%3D

    Article  PubMed  CAS  Google Scholar 

  7. SR Cummings DM Black DE Thompson WB Applegate E Barrett-Connor et al. (1998) ArticleTitleEffect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture intervention Trial JAMA 280 2077–2082 Occurrence Handle9875874 Occurrence Handle10.1001/jama.280.24.2077 Occurrence Handle1:CAS:528:DyaK1MXjsVWruw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  8. DM Black DE Thompson DC Bauer K Ensrud MCT Musliner et al. (2000) ArticleTitleFracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group J Clin Endocrinol Metab 85 4118–4124 Occurrence Handle11095442 Occurrence Handle10.1210/jc.85.11.4118 Occurrence Handle1:CAS:528:DC%2BD3cXotlWnurw%3D

    Article  PubMed  CAS  Google Scholar 

  9. J Reginster HW Minne OH Sorensen M Hooper C Roux et al. (2000) ArticleTitleRandomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group Osteoporos Int 11 83–91 Occurrence Handle10663363 Occurrence Handle10.1007/s001980050010 Occurrence Handle1:CAS:528:DC%2BD3cXhvFGgsr0%3D

    Article  PubMed  CAS  Google Scholar 

  10. ST Harris NB Watts HK Genant CD McKeever T Hangartner et al. (1999) ArticleTitleEffects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group JAMA 282 1344–1352 Occurrence Handle10527181 Occurrence Handle10.1001/jama.282.14.1344 Occurrence Handle1:CAS:528:DyaK1MXmvFansr0%3D

    Article  PubMed  CAS  Google Scholar 

  11. K Kushida M Shiraki T Nakamura H Kishimoto H Morii et al. (2004) ArticleTitleAlendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: 3-year follow-up study J Bone Miner Metab 22 462–468 Occurrence Handle15316867 Occurrence Handle10.1007/s00774-004-0508-0 Occurrence Handle1:CAS:528:DC%2BD2cXmslCit7c%3D

    Article  PubMed  CAS  Google Scholar 

  12. K Kushida M Fukunaga H Kishimoto M Shiraki A Itabashi et al. (2004) ArticleTitleA comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial J Bone Miner Metab 22 469–478 Occurrence Handle15316868 Occurrence Handle1:CAS:528:DC%2BD2cXmslCit7g%3D

    PubMed  CAS  Google Scholar 

  13. Y Nishizawa T Nakamura H Ohta K Kushida I Gorai et al. (2005) ArticleTitleGuideline for the use of biochemical markers of bone turnover in osteoporosis (2004) J Bone Miner Metab 23 97–104 Occurrence Handle15750686 Occurrence Handle10.1007/s00774-004-0547-6

    Article  PubMed  Google Scholar 

  14. FA McAlister A Laupacis GA Wells DL Sackett (1999) ArticleTitleUsers’ guides to the medical literature: XIX. Applying clinical trial results. B. Guidelines for determining whether a drug is exerting (more than) a class effect JAMA 282 1371–1377 Occurrence Handle10527185 Occurrence Handle10.1001/jama.282.14.1371 Occurrence Handle1:STN:280:DyaK1MvlsVejuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  15. HC Bucher GH Guyatt DJ Cook A Holbrook FA McAlister (1999) ArticleTitleUsers’ guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate endpoints. Evidence based medicine working group JAMA 282 771–778 Occurrence Handle10463714 Occurrence Handle10.1001/jama.282.8.771 Occurrence Handle1:STN:280:DyaK1MzptFemtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  16. S Sarkar JY Reginster GG Crans A Diez-Perez KV Pinette et al. (2004) ArticleTitleRelationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk J Bone Miner Res 19 394–401 Occurrence Handle15040827 Occurrence Handle10.1359/JBMR.0301243

    Article  PubMed  Google Scholar 

  17. DC Bauer DM Black P Garnero M Hochberg S Ott et al. (2004) ArticleTitleChanges in bone turnover and hip, nonspine, and vertebral fracture in alendronate-treated women: the fracture intervention trial J Bone Miner Res 19 1250–1258 Occurrence Handle15231011 Occurrence Handle10.1359/JBMR.040512

    Article  PubMed  Google Scholar 

  18. MC Hochberg S Greenspan RD Wasnich P Miller DE Thompson et al. (2002) ArticleTitleChanges in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents J Clin Endocrinol Metab 87 1586–1592 Occurrence Handle11932287 Occurrence Handle10.1210/jc.87.4.1586 Occurrence Handle1:CAS:528:DC%2BD38XivFKlt7k%3D

    Article  PubMed  CAS  Google Scholar 

  19. NH Bjarnason S Sarkar T Duong B Mitlak PD Delmas et al. (2001) ArticleTitleSix and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis Osteoporos Int 12 922–930 Occurrence Handle11808544 Occurrence Handle10.1007/s001980170020 Occurrence Handle1:CAS:528:DC%2BD38XkslSkug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  20. Y Ogura A Gonsho JC Cyong H Orimo (2004) ArticleTitleClinical trial of risedronate in Japanese volunteers: single and multiple oral dose studies J Bone Miner Metab 22 111–119 Occurrence Handle14999521 Occurrence Handle10.1007/s00774-003-0458-y Occurrence Handle1:CAS:528:DC%2BD2cXhsl2ht7s%3D

    Article  PubMed  CAS  Google Scholar 

  21. D Hosking S Adami D Felsenberg J Cannata Andia M Valimaki et al. (2003) ArticleTitleComparison of change in bone resorption and bone mineral density with once weekly alendronate and daily risedronate: a randomized placebo-controlled study Curr Med Res Opin 19 383–394 Occurrence Handle13678475 Occurrence Handle10.1185/030079903125002009 Occurrence Handle1:CAS:528:DC%2BD3sXnsVGitrY%3D

    Article  PubMed  CAS  Google Scholar 

  22. A Cranney G Guyatt L Griffith G Wells P Tugwell et al. (2002) ArticleTitleMeta-analyses of therapies for postmenopausal osteoporosis. IX. Summary of meta-analyses of therapies for postmenopausal osteoporosis Endocr Rev 23 570–577 Occurrence Handle12202472 Occurrence Handle10.1210/er.2001-9002 Occurrence Handle1:CAS:528:DC%2BD38Xnt1Whs78%3D

    Article  PubMed  CAS  Google Scholar 

  23. CJ Rosen MC Hochberg SL Bonnick M McClung P Miller et al. (2005) ArticleTitleTreatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study J Bone Miner Res 20 141–151 Occurrence Handle15619680 Occurrence Handle10.1359/jbmr.2005.20.1.141 Occurrence Handle1:CAS:528:DC%2BD2MXptValtA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  24. JA Kanis A Oden O Johnell F Caulin H Bone et al. (2002) ArticleTitleUncertain future of trials in osteoporosis Osteoporos Int 13 443–449 Occurrence Handle12107656 Occurrence Handle10.1007/s001980200052 Occurrence Handle1:STN:280:DC%2BD38zmsFOktQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Orthopedic Surgery, Chitose City Hospital, 2-1-1 Hokko, Chitose, Hokkaido, 066-8550, Japan

    Junichi Takada & Kenshi Imoto

  2. Department of Orthopedic Surgery, Sapporo Medical University, Sapporo, Japan

    Junichi Takada, Kousuke Iba & Toshihiko Yamashita

Authors
  1. Junichi Takada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kousuke Iba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenshi Imoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshihiko Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Junichi Takada.

About this article

Cite this article

Takada, J., Iba, K., Imoto, K. et al. Changes in bone resorption markers among Japanese patients with postmenopausal osteoporosis treated with alendronate and risedronate. J Bone Miner Metab 25, 142–146 (2007). https://doi.org/10.1007/s00774-006-0739-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-006-0739-3

Key words

Search

Navigation